Table 2.
Group A (≤12 months) n=201 No. (%) |
Group B (>12 months) n=203 No. (%) |
P value | |
Type of metastatic presentation (distant relapse)* | 0.195 | ||
Visceral | 139 (69) | 128 (63) | |
Non-visceral | 62 (31) | 75 (37) | |
Metastatic site (distant relapse)† | 0.073 | ||
Brain | 52 (26) | 31 (15) | |
Liver | 46 (23) | 60 (30) | |
Lung | 37 (18) | 33 (16) | |
Bone | 43 (21) | 51 (25) | |
Others | 23 (11) | 28 (14) | |
Type of metastatic presentation (distant relapse)* | 0.289 | ||
Visceral | 139 (77) | 128 (72) | |
Bone (without visceral) | 42 (23) | 50 (28) |
*Patients with bone, skin, lymph node and soft tissue were considered as non-visceral; all the others were considered as visceral.
†For patients who developed relapse in more than one organ, the first site of distant metastasis was defined by prespecified importance in the following order: brain, liver, lung, bone and others. The category ‘others’ included: skin, lymph node, soft tissue, pleura and other rarer sites of relapse.